The Management of New Patients Diagnosed with Major Depressive Disorder in General Practice Surgery: A Clinical Audit

Abstract

Introduction Major depressive disorder is a mood disorder that may lead to a loss of interest, sadness, or a lack of self-esteem. It is one of the most common cognitive diseases in the United Kingdom, with an estimated incidence of one in six adults. We aimed to conduct a clinical audit to discuss the newly diagnosed depression management guidelines in the National institute for health and care excellence NICE guidelines 2022 in general practice surgery. Methods Based on 22 standards, the clinical audit evaluated GP in conformity with NICE guidelines 2022 [NG222] regarding depression management for new patients. The audit will be compared against the standards and similar audits in the literature review. The data were collected for 77 patients, and statistical analysis was carried out using SPSS Statistics software version 29 (SPSS). Findings The results were significant regarding discussing treatment options and antidepressant preferences according to the patients, such as standards one, three, and five. Also, the pharmacological treatment was statistically significant (p < 0.001). Discussion Pharmacological treatment corresponded significantly to the NICE guidelines 2022, because most patients were on SSRI medications, the first line of treatment recommended for LS and MS depression. However, psychological therapy needed more explanation and adherence, and patient follow-up needed to be improved to ensure that the patient received medications regularly for six months.